v.231201
Showing details for project SYSMHC00046
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
SYSMHC00046_Seq |
6 |
Human |
|
|
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
Detailed view of sample SYSMHC00046_Seq
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
SYSMHC00046 |
SYSMHC00046_Seq |
Seq51737_QE3.raw |
Human |
In vitro |
Lung |
Adenocarcinoma cell |
suspension |
Lung cancer |
|
class I |
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
30833945 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Ultimate 3000 RSLC nano-capillary UHPLC or Easy nLC 1000 capillary HPLC |
no |
DDA |
HCD |
|
|
|
1 |
SYSMHC00046 |
SYSMHC00046_Seq |
Seq51736_QE3.raw |
Human |
In vitro |
Lung |
Adenocarcinoma cell |
suspension |
Lung cancer |
|
class I |
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
30833945 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Ultimate 3000 RSLC nano-capillary UHPLC or Easy nLC 1000 capillary HPLC |
no |
DDA |
HCD |
|
|
|
2 |
SYSMHC00046 |
SYSMHC00046_Seq |
Seq51738_QE3.raw |
Human |
In vitro |
Lung |
Adenocarcinoma cell |
suspension |
Lung cancer |
|
class I |
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
30833945 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Ultimate 3000 RSLC nano-capillary UHPLC or Easy nLC 1000 capillary HPLC |
no |
DDA |
HCD |
|
|
|
3 |
SYSMHC00046 |
SYSMHC00046_Seq |
Seq51734_QE3.raw |
Human |
In vitro |
Lung |
Adenocarcinoma cell |
suspension |
Lung cancer |
|
class I |
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
30833945 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Ultimate 3000 RSLC nano-capillary UHPLC or Easy nLC 1000 capillary HPLC |
no |
DDA |
HCD |
|
|
|
4 |
SYSMHC00046 |
SYSMHC00046_Seq |
Seq51735_QE3.raw |
Human |
In vitro |
Lung |
Adenocarcinoma cell |
suspension |
Lung cancer |
|
class I |
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
30833945 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Ultimate 3000 RSLC nano-capillary UHPLC or Easy nLC 1000 capillary HPLC |
no |
DDA |
HCD |
|
|
|
5 |
SYSMHC00046 |
SYSMHC00046_Seq |
Seq51739_QE3.raw |
Human |
In vitro |
Lung |
Adenocarcinoma cell |
suspension |
Lung cancer |
|
class I |
HLA-C12:03,HLA-B44:03,HLA-B18:01,HLA-A30:01,HLA-A25:01 |
30833945 |
native |
Immunoaffinity |
W6/32 |
Q-Exactive |
Ultimate 3000 RSLC nano-capillary UHPLC or Easy nLC 1000 capillary HPLC |
no |
DDA |
HCD |
|
|
|
6 |